OTCM
AFIB
Market cap59kUSD
Jul 07, Last price
0.00USD
1D
0.00%
1Q
-94.88%
IPO
-99.99%
Name
Acutus Medical Inc
Chart & Performance
Profile
Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. The company's product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|
2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | |
Income | |||||||
Revenues | 20,157 181.37% | 7,164 -56.22% | 16,363 -5.21% | ||||
Cost of revenue | 19,144 | 13,783 | 60,063 | ||||
Unusual Expense (Income) | |||||||
NOPBT | 1,013 | (6,619) | (43,700) | ||||
NOPBT Margin | 5.03% | ||||||
Operating Taxes | 63 | 82 | |||||
Tax Rate | |||||||
NOPAT | 1,013 | (6,682) | (43,782) | ||||
Net income | (9,547) -88.31% | (81,663) 106.14% | (39,616) -67.89% | ||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | (82) | (44) | |||||
BB yield | 1.40% | 0.13% | |||||
Debt | |||||||
Debt current | 7,962 | 3,300 | 319 | ||||
Long-term debt | 30,997 | 39,858 | 42,959 | ||||
Deferred revenue | |||||||
Other long-term liabilities | 12 | ||||||
Net debt | 24,940 | 20,755 | (27,669) | ||||
Cash flow | |||||||
Cash from operating activities | (31,660) | (63,608) | (85,032) | ||||
CAPEX | (219) | (3,983) | |||||
Cash from investing activities | 22,149 | 58,555 | 104,750 | ||||
Cash from financing activities | (2,891) | (2,664) | (12,116) | ||||
FCF | 3,175 | 16,293 | (53,385) | ||||
Balance | |||||||
Cash | 14,019 | 22,403 | 70,447 | ||||
Long term investments | 500 | ||||||
Excess cash | 13,011 | 22,045 | 70,129 | ||||
Stockholders' equity | (610,262) | (600,814) | (519,154) | ||||
Invested Capital | 634,434 | 639,132 | 632,402 | ||||
ROIC | 0.16% | ||||||
ROCE | 4.19% | ||||||
EV | |||||||
Common stock shares outstanding | 29,768 | 29,095 | 28,471 | ||||
Price | 0.06 -72.76% | 0.20 -82.44% | 1.15 -66.28% | ||||
Market cap | 1,637 -72.13% | 5,874 -82.06% | 32,742 -66.49% | ||||
EV | 26,577 | 26,629 | 5,073 | ||||
EBITDA | 2,040 | (5,745) | (36,571) | ||||
EV/EBITDA | 13.03 | ||||||
Interest | 5,758 | 5,655 | 5,149 | ||||
Interest/NOPBT | 568.41% |